Financial results - ASEPTICA PHARMA SRL

Financial Summary - Aseptica Pharma Srl
Unique identification code: 7589249
Registration number: J40/12088/2010
Nace: 4646
Sales - Ron
180.951
Net Profit - Ron
1.525
Employees
3
Open Account
Company Aseptica Pharma Srl with Fiscal Code 7589249 recorded a turnover of 2024 of 180.951, with a net profit of 1.525 and having an average number of employees of 3. The company operates in the field of Comerţ cu ridicata al produselor farmaceutice și medicale having the NACE code 4646.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Aseptica Pharma Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 23.781 30.186 60.797 122.209 179.567 232.292 184.170 192.136 171.980 180.951
Total Income - EUR 23.781 31.020 61.633 122.989 180.018 232.645 186.429 194.362 173.802 183.687
Total Expenses - EUR 19.114 13.735 56.330 116.707 168.895 200.449 184.164 180.990 169.482 181.388
Gross Profit/Loss - EUR 4.668 17.284 5.303 6.282 11.123 32.196 2.265 13.372 4.320 2.299
Net Profit/Loss - EUR 3.954 16.358 4.695 5.059 9.327 30.056 440 11.624 2.780 1.525
Employees 2 2 2 3 4 4 3 3 3 3
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 5.8%, from 171.980 euro in the year 2023, to 180.951 euro in 2024. The Net Profit decreased by -1.239 euro, from 2.780 euro in 2023, to 1.525 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Aseptica Pharma Srl

Rating financiar

Financial Rating -
ASEPTICA PHARMA SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Aseptica Pharma Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Aseptica Pharma Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Aseptica Pharma Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Aseptica Pharma Srl - CUI 7589249

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 2.259 5.368 5.135 3.117 2.972 4.204 7.874 5.461 15.356 14.004
Current Assets 8.309 26.742 57.674 71.352 83.792 96.789 89.829 106.791 102.155 97.170
Inventories 12 6.433 31.704 31.595 32.863 38.128 32.433 35.669 39.714 27.762
Receivables 2.989 7.275 19.274 37.885 45.364 49.994 38.218 45.924 40.182 48.564
Cash 5.308 13.034 6.696 1.872 5.565 8.666 19.177 25.197 22.260 20.844
Shareholders Funds 14.598 19.810 24.170 28.785 37.554 66.898 65.854 77.683 80.228 81.305
Social Capital 63 312 306 301 295 289 283 284 283 281
Debts 1.636 17.951 44.099 51.377 55.043 40.339 40.601 47.517 50.192 42.706
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4646 - 4646"
CAEN Financial Year 4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 97.170 euro in 2024 which includes Inventories of 27.762 euro, Receivables of 48.564 euro and cash availability of 20.844 euro.
The company's Equity was valued at 81.305 euro, while total Liabilities amounted to 42.706 euro. Equity increased by 1.525 euro, from 80.228 euro in 2023, to 81.305 in 2024.

Risk Reports Prices

Reviews - Aseptica Pharma Srl

Comments - Aseptica Pharma Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.